Calton & Associates, Inc. Neogenomics Inc Transaction History

Calton & Associates, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$6.45 - $12.07 $92,093 - $172,335	14,278 New	14,278 $0
Q2 2022 Jul 12, 2022	SELL	$7.06 - $13.97 $73,106 - $144,659	-10,355 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$12.15 - $35.28 $125,813 - $365,324	10,355 New	10,355 $125,000
Q4 2021 Jan 13, 2022	SELL	$30.49 - $48.49 $155,102 - $246,668	-5,087 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$41.66 - $52.52 $1,624 - $2,048	-39 Reduced 0.76%	5,087 $245,000
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $5,822 - $8,218	-159 Reduced 3.01%	5,126 $232,000
Q1 2021 May 03, 2021	BUY	$41.56 - $59.88 $19,948 - $28,742	480 Added 9.99%	5,285 $255,000
Q4 2020 Jan 25, 2021	BUY	$36.08 - $56.47 $173,364 - $271,338	4,805 New	4,805 $259,000

283

123M

622K

72.2K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.81B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.